Canadian Cardiovascular Society

CCS/HSRLCE/BI-Lilly Cardiometabolic Research Award

The Canadian Cardiovascular Society (CCS), Heart & Stroke / Richard Lewar Centre of Excellence in Cardiovascular Research (HSRLCE), and the BI-Lilly Alliance have collaboratively created an award, entitled “CCS/HSRLCE/BI-Lilly-Cardiometabolic Research Award”.

This Award is intended for trainees/residents enrolled in a Canadian clinical training program and early career researchers who are within five (5) years of their first faculty appointment at a Canadian academic institution, for a research project on any topic related to cardiometabolic disease.

A total of four (4) awards totaling $70K will be awarded based on an independent peer review process. Funded research must be completed within 48 months from the start of funding.

Deadline: Wednesday, August 11th, 2021 at 11:59 AM EST

CCS/HSRLCE/BI-Lilly Cardiometabolic Research Award Handbook


Eligibility

Applicants must be either:

  • a Trainee/Resident enrolled in a Canadian clinical training program; or
    – PhDs and MDs who are within five years of their first faculty appointment at a Canadian academic institution.
  • an early career researcher within the first 5 years of their first faculty appointment at a Canadian academic institution.
  • Applicants must be a Canadian Citizen or Permanent Resident of Canada. 
  • Award funds are solely intended for Canadian research purposes. 
  • The award and funds are intended for original research conducted by residents and should not supplement funding for an ongoing project. 
    • If the submission refers to a multicenter clinical trial, the applicant must specify their specific role in the research study. 
    • If the application is for a sub-study of an ongoing project or trial, the applicant must specify their role and explain how the sub-study is distinct from the main study. 
  • Funded research must be completed within 48 months from the start of funding. 
  • Research status report will be requested and should be submitted on October 1st of the ensuing year(s) that the project is running. 
  • Applicants must be available to present their research projects to the judging panel during a digital session at the Canadian Cardiovascular Congress (CCC), in October 2021. Finalists will be provided complimentary registration to CCC 2021. 

The Award

A total of four (4) awards totaling $70K will be awarded as follows.

2 Awards for Residents/Trainees:  
$20,000  
$15,000  

2 Awards for Early Career Members:  
$20,000  
$15,000  

Funds will be administered by the Cardiology Division of the awardee’s affiliated university or equivalent.

The Peer Review Process and Evaluation Committee

All applications will be pre-screened for eligibility. Applications that are late, incomplete and/or do not meet the basic eligibility criteria will not be considered for review.

Peer review of all eligible applications will be conducted by a scientific review committee comprised of CCS members selected for their subject matter expertise. All eligible proposals will be reviewed by at least two members of the peer review committee.

These four (4) finalists will present their research project at a session held during the Canadian Cardiovascular Congress (CCC) in October 2021. During a 10-minute presentation, they will have the opportunity to present the research project and answer questions from the Peer Review Committee.

Following the four (4) presentations, each of the two (2) finalists in each category will be awarded a Cardiometabolic Research Award.

Budget Template

Download the 2021 Budget template here.


If you have any questions or require support preparing or submitting your application, please email researchawards@ccs.ca.

Supported by:

The Canadian Cardiovascular Society, Heart & Stroke / Richard LewarCentre of Excellence in Cardiovascular Research, and the BI-Lilly Alliance are proud to support the CCS-HSRLCE-BI-Lilly Cardiometabolic Research Award. With this award, we hope to further research on the link between cardiovascular disease in diabetes to improve thelives of Canadians who are affected by these conditions, and their families

Back to top